Methods: This study aimed to investigate alterations in serum levels of brain-derived neurotrophic factor (BDNF) and Interleukin-1β (IL-1β) in individuals with depression and assess their potential roles as biomarkers. This was a case-control study. Here, IL1B is linked to depressive symptom measurement.